Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Family Medicine
Diabetes Mellitus, Type 1 Clinical Trials
A listing of Diabetes Mellitus, Type 1 medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Tuscon : University of Arizona
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Chandler : Investigational Site Number 840156
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Arkansas
Little Rock : Investigational Site Number 840177
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
California
Anaheim : Anaheim Clinical Trials (ACT)
Patients with Type I Diabetes needed for a clinical research trial.
Duarte : City of Hope
Detection of Human Beta Cell Death in T1DM Methylation-Specific PCR
Duarte : City of Hope
Long-Term Follow-Up of Islet Transplant Recipients
Duarte : City of Hope
TrialNet TN-01: Trialnet Natural History Study of the Development of Type I Diabetes
Escondido : AMCR Institute, Inc. Updated
A 52- Week Study to Compare the Glycemic Effects, Safety and Tolerability of A 52- Week Study to Evaluate the Safety and Efficacy of CBX129801 in Patients with Type 1 Diabetes With Mild to Moderate Diabetic Peripheral Neuropathy
Escondido : AMCR Institute, Inc. Updated
A Comparison of the Study Medication Once Daily at a Fixed Time to the Study Medication at a Variable Time in Patients With Diabetes Mellitus Type 1
Escondido : AMCR Institute, Inc.
Do you want to try a new glucose meter?
Escondido : AMCR Institute, Inc. Updated
Evaluation of Metabolic Outcomes and Safety of Hylenex Recombinant Used as Pre-administration Infusion Site Treatment in Patients With Diabetes Mellitus Type 1 on Insulin Pump
Escondido : AMCR Institute, Inc. Updated
The Natural History Study of the development of Type 1 Diabetes Screening Blood Test to Identify Increased Risk of Diabetes Mellitus Type 1
Los Angeles : Children’s Hospital of Los Angeles
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Sacramento : Sutter Institute for Medical Research (SIMR)
Diabetes Type 1 - Genetics
San Diego : UCSD Rady Children’s Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
View More »
Anaheim : Anaheim Clinical Trials, LLC
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Bell Gardens : Investigational Site Number 840430
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Chula Vista : Profil Research Institute
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Chula Vista : Profil Institute For Clinical Research, Inc.
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Concord : John Muir Physician Network Clinical Research Center
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Escondido : Investigational Site Number 840131
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Escondido : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Fresno : Investigational Site Number 840140
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Fresno : Research Center of Fresno
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Fresno : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Greenbrae : Investigational Site Number 840107
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Huntington Beach : Investigational Site Number 840149
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Irvine : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
La Jolla : Scripps Whittier Diabetes Institute
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
La Jolla : Investigational Site Number 840120
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
La Jolla : Investigational Site Number 840123
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
La Mesa : Investigational Site Number 840159
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Long Beach : Investigational Site Number 840114
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Long Beach : Health Care Partners Medical Group
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Los Gatos : Private Practice - Richard Cherlin, MD.
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Los Gatos :
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Mission Hills : Investigational Site Number 840189
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Modesto : Sutter Gold Medical Foundation
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Salinas : Diabetes Care Center
A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections
San Diego : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2605541 Versus Insulin Glargine on Blood Sugar
San Diego : Va San Diego Healthcare System
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
San Diego : San Diego Clinical Trials
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
San Diego : Accelovance Inc.
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
San Diego : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
San Francisco : Monteagle Medical Center
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
San Mateo : Mills-Peninsula Health Services
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Stanford : Stanford University and Stanford Hospital & Clinics
Medtronic Treat to Range (TTR) Closed-Loop Control
Temecula : Investigational Site Number 840105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Torrance : La Biomed Research Inst. At Harbor Ucla Med Ctr.
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Torrance : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Tustin : Investigational Site Number 840155
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Tustin : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Walnut Creek : Investigational Site Number 840115
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Walnut Creek : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Colorado
Aurora : University of Colorado, Barbara Davis Center for Childhood Diabetes
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Aurora : University of Colorado, Barbara Davis Center for Childhood Diabetes
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Aurora : University of Colorado Hospital - Anschutz Outpatient Pavilion
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Aurora : Barbara Davis Center
Pramlintide in Adolescents With Type 1 Diabetes
Denver : Investigational Site Number 840160
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Denver : Investigational Site Number 840188
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Denver : Creekside Endocrine Associates, Inc.
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Longmont : Investigational Site Number 840143
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Connecticut
New Haven : Investigational Site Number 840196
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Delaware
Wilmington : Alfred I duPont Hospital
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
District of Columbia
Washington : Investigational Site Number 840104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Washington : George Washington University Medical Faculty Associates
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Florida
Miami : University of Miami School of Medicine
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Miramar : Comprehensive Clinical Development - Miramar, FL
Overweight Men and Women Including Type 2 Diabetics
West Palm Beach : Metabolic Research Institute, Inc.
Do you have Type 1 Diabetes? Are your blood sugar levels still too high on your current insulin regimen?
View More »
Aventura : Innovative Medical Research of South Florida Inc.
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Boca Raton : Investigational Site Number 840152
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Bradenton : Investigational Site Number 840113
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
DeLand :
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Hialeah : Investigational Site Number 840102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Hollywood : The Center for Diabetes and Endocrine Care
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Hollywood : Investigational Site Number 840134
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Jacksonville : Investigational Site Number 840185
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Jacksonville : Nemours Children's Clinic
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Miami : University of Miami Diabetes Research Institute
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Miami : Investigational Site Number 840118
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Miami : Investigational Site Number 840179
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Miami : Investigational Site Number 840126
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Miami : Investigational Site Number 840138
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
New Port Richey : Investigational Site Number 840117
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
North Miami Beach : Investigational Site Number 840183
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Orlando : Compass Research Phase 1, Llc
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Orlando : Investigational Site Number 840174
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Orlando : Orlando Diabetes & Endocrine Specialists, P.A.
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Orlando : Nemours Children's Clinic
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Oviedo : Investigational Site Number 840110
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Palm Harbor : Investigational Site Number 840178
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Pensacola : Nemours Children's Clinic
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Port Orange : Progressive Medical Research Pharmaseek
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Port Orange : Progressive Medical Research
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Tallahassee : Tallahassee Endocrine Associates
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Tampa : Investigational Site Number 840181
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Tampa : Diabetes and Hormonal Disease Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
West Palm Beach : Investigational Site Number 840420
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Georgia
Atlanta : Pinnacle Trials, Inc.
Do you have both Diabetes & Asthma?
Atlanta : Children’s Healthcare of Atlanta at Egleston
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Atlanta : Atlanta Diabetes Associates
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Atlanta : Emory's Children's Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Atlanta : Atlanta Diabetes Associates
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Atlanta : Investigational Site Number 840195
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Atlanta : Atlanta Diabetes Associates
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Decatur : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Roswell : Endocrine Research Solutions
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Hawaii
Honolulu : Investigational Site Number 840124
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Idaho
Idaho Falls : Rocky Mountain Diabetes and Osteoporosis Center PA
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Idaho Falls : Investigational Site Number 840167
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Idaho Falls : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Nampa : Investigational Site Number 840163
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Illinois
Chicago : Cedar-Crosse Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Springfield : Investigational Site Number 840162
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Indiana
Indianapolis : Riley Hospital for Children, Indiana University
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Avon : Investigational Site Number 840172
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Indianapolis : Investigational Site Number 840197
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Iowa
Iowa City : University of Iowa
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Iowa City : University of Iowa Health Care
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Des Moines : Investigational Site Number 840108
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Iowa City : Investigational Site Number 840407
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Kansas
Overland Park : Vince And Associates Clinical Research
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Topeka : Investigational Site Number 840170
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Wichita : MidAmerica Diabetes Associates, PA
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Wichita : Investigational Site Number 840129
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Kentucky
Lexington : Kentucky Diabetes
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Lexington : Central Kentucky Research Associates, Inc.
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Lexington : Investigational Site Number 840421
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Lexington : Kentucky Diabetes Endocrinology Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Louisiana
Metairie : Investigational Site Number 840426
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
New Orleans : Louisiana Research Associates, Inc.
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
New Orleans : Investigational Site Number 840164
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Maryland
Baltimore : University of Maryland Medical Center
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Baltimore : University of Maryland Medical Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Rockville : Diabetes & Glandular Disease Research
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Rockville : Investigational Site Number 840180
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Massachusetts
Boston : Massachusetts General Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Boston : Joslin Diabetes Center
Study to Prevent Kidney Disease in Type 1 Diabetes
Boston : Massachusetts General Hospital
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Boston : Joslin Diabetes Center
TrialNet Natural History Study for the Prevention of Type 1 Diabetes
Worcester : UMASS Memorial Medical Center
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
View More »
Boston : Investigational Site Number 840409
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Boston : Massachusettes General Hospital/ Diabetes Research Center
Comparison of Lantus and NPH Insulin in the Dawn Phenomenon
Boston : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Haverhill : Investigational Site Number 840137
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Michigan
Ann Arbor : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Detroit : Henry Ford Health System
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Detroit : Investigational Site Number 840408
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Kalamazoo : Jasper Clinic, Inc.
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Madison Heights : Investigational Site Number 840153
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Minnesota
Minneapolis : University of Minnesota
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Rochester : Mayo Clinic
Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis
St Louis Park : Investigational Site Number 840171
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Missouri
Hazelwood : Healthcare Research Network
Do you have Diabetic Foot Pain? Are you 18+ years old? If so, you may qualify for our study! Call us today to find out more information.
Kansas City : Children’s Mercy Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Kansas City : The Children’s Mercy Hospital
T1DAL: Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
Kansas City : Dybedal Clinical Research Center
Type 1 Diabetes
St. Louis : Washington University in St. Louis - Center for Clinical Studies
Young Adults Are Needed for a Research Study on Type 1 Diabetes at Washington University.
View More »
Kansas City : Kansas City University Of Medicine And Biosciences
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
St Louis : Investigational Site Number 840184
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
St. Louis : Washington University
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Montana
Billings : Investigational Site Number 840406
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Billings : Billings Clinic Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Butte : Mercury Street Medical
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Nebraska
Omaha : Creighton University
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Omaha : Investigational Site Number 840106
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Omaha : Investigational Site Number 840145
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Omaha : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Nevada
Henderson : Desert Endocrinolgy
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Las Vegas : Investigational Site Number 840139
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Las Vegas : Palm Medical Research Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Las Vegas : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
New Jersey
Hackensack : Advanced Biomedical Research, Inc. (ABR)
Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes
New Mexico
Albuquerque : Investigational Site Number 840151
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Santa Fe : Soutwest Clinical Research Center, LLC
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
New York
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
Exenatide (Byetta) vs Pramlintide (Symlin) Role in Post-Prandial Hyperglycemia
Bronx : Einstein-Montefiore Institute for Clinical & Translational Research
New Onset Type 1 Diabetes: Role of Exenatide
Bronx : Biomedical Research Alliance of New York
Type 1 Diabetes- two different insulin treatments.
New York : Naomi Berrie Diabetes Center
Proleukin and Rapamune in Type 1 Diabetes
New York : Naomi Berrie Diabetes Center at Columbia University Medical Center
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
New York : Columbia University
The ACCESS Trial for lupus with kidney disease (lupus nephritis)
Rochester : University of Rochester Medical Center, Strong Children’s Research Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Bronx : Albert Einstein College of Medicine West Campus CRC
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
New Hyde Park : Investigational Site Number 840191
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
New Hyde Park : North Shore Diabetes and Endocrine Associates
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : MedHex Health
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
New York : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Syracuse : Research Foundation of SUNY Upstate Medical University
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Syracuse : Investigational Site Number 840173
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Williamsville : Diabetes-Endocrinology Center of Western NY
Liraglutide in the Treatment of Type 1 Diabetes Mellitus
North Carolina
Durham : University of North Carolina, Diabetes Care Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Asheville : Investigational Site Number 840133
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Ashville : Mountain Diabetes and Endocrine Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Chapel Hill : Investigational Site Number 840175
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Durham : University of North Carolina Diabetes Care Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Greensboro : Investigational Site Number 840142
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Mooresville : Investigational Site Number 840154
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Morehead City : Diabetes & Endocrinology Consultants, PC
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Morganton : Investigational Site Number 840161
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Ohio
Cincinnati : Community Research
Diabetic struggling with your weight?
Columbus : Nationwide Children’s Hospital
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
View More »
Cincinnati : Sentral Clinical Research Services, LLC
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Cincinnati : The Lindner Research Center, The Christ Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Cleveland : Cleveland Clinic
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Mentor : Investigational Site Number 840169
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Oklahoma
Norman : Investigational Site Number 840119
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Oregon
Bend : Investigational Site Number 840112
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Portland : Oregon Health Sciences University
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Portland : Research Site Updated
Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM
Portland : Legacy Clinical Research & Technology Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Pennsylvania
Philadelphia : Children’s Hospital of Philadelphia
RETAIN (Part I): A Research Trial of Aralast in New Onset Type 1 Diabetes
Philadelphia : Children’s Hospital of Philadelphia
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Philadelphia : Investigational Site Number 840128
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Philadelphia : Nemours Children's Clinic-Jefferson
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
South Carolina
Greer : Investigational Site Number 840136
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
South Dakota
Dakota Dunes : Investigational Site Number 840122
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Rapid City : Regional Medical Clinic-Endocrinology
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Tennessee
Bartlett : AM Diabetes & Endocrinology Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Chattanooga : Investigational Site Number 840144
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Nashville : Investigational Site Number 840187
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Texas
Dallas : University of Texas Southwestern
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Austin : Texas Diabetes and Endocrinology
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Austin : Investigational Site Number 840109
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Austin : Investigational Site Number 840157
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Dallas : Baylor Endocrine Center
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Dallas : Research Institute of Dallas
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Dallas : Dallas Diabetes and Endocrine Research Center
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Dallas : Mountain Diabetes & Endrocrine Center
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Dallas : Dallas Diabetes & Endocrine Center
BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes
Dallas : Investigational Site Number 840412
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Dallas : Investigational Site Number 840150
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Dallas : Diabetech
Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes
Dallas : UT Southwestern Medical Center
Effects of Metreleptin in Type 1 Diabetes Mellitus
Dallas : Research Institute of Dallas
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Dallas : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Dallas : Lexicon Investigational Site
Safety and Efficacy of LX4211 in Patients With Inadequately Controlled Type 1 Diabetes Mellitus
Houston : Investigational Site Number 840141
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Houston : Investigational Site Number 840130
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Houston : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Round Rock : Texas Diabetes and Endocrinology
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
San Antonio : Sonterra Clinical Research
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
San Antonio : Investigational Site Number 840166
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
San Antonio : Cetero Research
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
San Antonio : SAM Clinical Research Center
Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
San Antonio : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Utah
Murray : Radiant Research - Salt Lake City
Clinical Research Study for Type 1 Diabetics
Murray : Radiant Research
Diabetes (Type 1) Research Study
View More »
Murray : Investigational Site Number 840101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Virginia
Burke : Investigational Site Number 840125
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Charlottesville : University of Virginia Center for Diabetes Technology
Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes
Charlottesville : University of Virginia
Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker
Chesapeake : Investigational Site Number 840427
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Manassas : Investigational Site Number 840103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Washington
Renton : Rainier Clinical Research Center, Inc.
Do you have Type 1 Diabetes? Rainier Clinical Research Center is seeking participants who have been diagnosed with type 1 diabetes and are interested in participating in a study of a new investigational insulin
Seattle : Benaroya Research Institute at Virginia Mason Research Center
T1DAL: A Clinical Research Trial of Inducing Remission in New-Onset Type 1 Diabetes with Alefacept
View More »
Olympia : Capital Clinical Research Center
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Renton : Ranier Clinical Research, Inc
A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)
Renton : Investigational Site Number 840132
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Seattle : Investigational Site Number 840403
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Seattle : Seattle Children's Hospital
The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
Spokane : Investigational Site Number 840402
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Spokane : Northside Internal Medicine Associates, PS
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Tacoma : Investigational Site Number 840127
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Tacoma : Chous Eye Care Associates
Diabetes Visual Function Supplement Study
Tacoma : Multicare Specialties Research
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Wisconsin
Madison : University of Wisconsin
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Milwaukee : Investigational Site Number 840411
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Argentina
San Martin : Hospital Interzonal General de Agudos Eva Perón
Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus
Australia
Perth : University of Western Australia
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Austria
Graz :
A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes
Graz : Medical University of Graz
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes
Innsbruck : Universitatsklinik fur Innere Medzin I, Landeskrankenhaus
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Vienna : Rudolfstiftung Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Belarus
Minsk : Belarusian Medical Academy of Postgraduate Education
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Minsk : Endocrinological Unit 1st City Clinical Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Minsk : Health Institution City Endocrinological Dispensary
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Minsk : Republican center of Medical Rehabilitation and Balneotherapy
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Mogilov : Health Institution Mogilev Diagnostic Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Brazil
Canada
Calgary : LMC Endocrinology Centres
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Calgary : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Coquitlam : Investigational Site Number 124110
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Laval : Investigational Site Number 124104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Laval : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
View More »
Mirabel : Investigational Site Number 124108
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Montreal : Investigational Site Number 124109
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Montreal : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
Oakville : LMC Endocrinology Centres
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Thornhill : Investigational Site Number 124105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Toronto : Hospital for Sick Children
Adolescent Type 1 Diabetes Cardio-Renal Intervention Trial
Toronto : Investigational Site Number 124101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Toronto : LMC Endocrinoly Centres
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Toronto : Updated
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
China
Beijing : Investigational Site Number 156001
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Beijing : Investigational Site Number 156006
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Beijing : Investigational Site Number 156007
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Changsha : Investigational Site Number 156009
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Guangzhou : Investigational Site Number 156008
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
View More »
Hangzhou : Investigational Site Number 156004
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Hangzhou : The First Affiliated Hospital of Zhejiang University
Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients
Jinan : General Hospital of Jinan Military Command
Stem Cell Educator Therapy in Type 1 Diabetes
Shanghai : Investigational Site Number 156016
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Shanghai : Investigational Site Number 156005
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Taiyuan : Investigational Site Number 156019
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Wuhan : Investigational Site Number 156002
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.
Czech Republic
Brno : Investigational Site Number 203102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Prague : Fakultni nemocnice Kralovske Vinohrady - II. internal department
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Prague : IKEM/Diabetes Centre/Videnska
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Praha 10 : Investigational Site Number 203104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Praha 8 : Investigational Site Number 203103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Denmark
Ålborg : Investigational Site Number 208102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Århus C :
A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes
Esbjerg : Investigational Site Number 208103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Gentofte : Investigational Site Number 208105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Gentofte : Steno Diabetes Center
Effect of CSII and CGM on Progression of Late Diabetic Complications
View More »
Hillerød : Hillerod Hospital
Recurrent Hypoglycaemia in Type 1 Diabetes
København Nv : Investigational Site Number 208104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Køge : Investigational Site Number 208107
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Estonia
Pärnu : Investigational Site Number 233104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Tallinn : Investigational Site Number 233105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Tartu : Investigational Site Number 233106
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Tartu : Investigational Site Number 233101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Viljandimaa : Investigational Site Number 233103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Finland
Kokkola : Investigational Site Number 246102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Kuopio : Investigational Site Number 246101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Loimaa : Investigational Site Number 246106
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Oulu : Investigational Site Number 246105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Oulu : Tutkimusyksikko
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Tampere : Investigational Site Number 246103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
France
Caen : CHU Côte de Nacre
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Dommartin les Touls : Hôpital Jeanne D'Arc
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Lyon : Hôpital Universitaire Debrousse
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Marseille : Hôpital Sainte Marguerite
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Montpellier : CH La Peyronie
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
View More »
Paris : Hotel Dieu Hospital
Diagnosis and Physiopathology of Insulin Allergy
Reims : American Memorial Hospital
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Toulouse : UH Toulouse
Effect of Autonomic Neuropathy on the Efficacy of a DPP-IV Inhibitor (Galvus) Therapy
Toulouse : CHU Rangueil
Obtain a Good Blood Glucose Control With the Paradigm Real Time System
Germany
Bad Mergentheim : Bad Mergentheim
The InsuPad in Daily Life Study
Dusseldorf : DDZ Studienzentrum Deutsches Diabetes Zentrum
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Giessen : Universitatsklinikum Giessen
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Hannover : Diabetes Centre for Children and Adolescents, Kinderkrankenhaus auf der Bult
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Munchen : Institut für Diabetesforschung an der Klinik und Hochschulambulanz für Kinder- und Jugendmedizin
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Munster : Institut für Diabetesforschung Münster GmbH
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Neuss : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
Neuss :
A Trial Investigating the Safety, Tolerability, and Distribution and Activity in the Body of NNC0148-0000-0287 Injected Under the Skin in Healthy Subjects and in Subjects With Type 1 Diabetes
Hungary
Budapest : Investigational Site Number 348103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Budapest : Investigational Site Number 348108
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Budapest : Investigational Site Number 348107
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Debrecen : Investigational Site Number 348106
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Gyula : Investigational Site Number 348102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
View More »
Szeged : University of Szeged Faculty of Medicin
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Urhida : Investigational Site Number 348101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Veszprem : Veszprem Megyei Csolnoky Ferenc Korhaz es Rendelointezet Diabetologia Centrum
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Zalaegerszeg : Zala Megyei Korhaz es Rendelointezet Diabetologia Centrum
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
India
Bangalore : Diacon Hospital,(Diabetes Care and Research Centre)
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Bangalore : Bangalore Diabetes Hospital
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Karnal : Bharti Research Institute of Diabetes and Endocrinology
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients
Israel
Beer Sheva : Diabetes Clinic Soroka University
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Beer Sheva : Soroka University Medical Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Beer-Sheva : Soroka University Medical Center
Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device
Haifa : Rambam Medical Cent
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Holon : Wolfson Medical Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Jerusalem : Hadassah Medical Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Jerusalem : Hadassah Medical Organization
Measuring and Monitoring Blood Glucose Levels Utilizing Non-invasive Blood Glucose Monitoring Device
Petach Tikva : Schneider Medical Center
Performance Study of the SOLO 2.0 Insulin Pump
Petach-Tiqva : Institute for Endocrinology and Diabetes Schneider Children's MC
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Tel Aviv : Sourasky Medical Center,
Performance Study of the SOLO 2.0 Insulin Pump
Zerifin : Assaf-Harofeh Medical Center
Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study
Italy
Grosseto : P.O. di Grosseto - Stabilimento Misericordia
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Mariano Comense : Az. Osp. S. Anna - Presidio Ospedaliero Cantù - Mariano Comense
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Milan : Istituto Scientifico San Raffaele
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Milan : Ospedale Niguarda Cà Granda
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Naples : II Università di Napoli Centro Regionale di Diabetologia Pediatrica "G. Stoppoloni"
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
View More »
Padua : Università degli Studi di Padova Dipartimento di Medicina Clinica e Sperimentale
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Palermo : . Endocrinologia e Malattie Metaboliche, Dipartimento biomedico di medicina interna e specialistica, Ex Istituto di clinica medica, Università di Palerm
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Pisa : Ospedale Cisanello
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Ravenna : U.O. di Diabetologia, Dip. di Malattie Digestive & Metaboliche
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Rome : University La Sapienza, Policlinico Umberto I
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Rome : Dept. of Endocrinology and Diabetes University Campus Bio-Medico
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Rome : Ospedale Sandro Pertini
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Turin : Azienda Ospedaliera-Universitaria S. Giovanni Battista
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
Japan
Aisai-Shi : Investigational Site Number 392110
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Amagasaki-Shi : Investigational Site Number 392119
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Chuo-Ku : Investigational Site Number 392106
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Chuo-Ku : Investigational Site Number 392107
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Ebina-Shi : Investigational Site Number 392110
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
View More »
Higashiosaka-Shi : Investigational Site Number 392115
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Ise-Shi : Investigational Site Number 392105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Izumisano-Shi : Investigational Site Number 392117
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Kamakura-Shi : Investigational Site Number 392109
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Karatsu-Shi : Investigational Site Number 392104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Kitakyushu-Shi : Investigational Site Number 392111
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Koriyama-Shi : Investigational Site Number 392101
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Kumamoto-Shi : Investigational Site Number 392001
Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus
Kurashiki-Shi : Investigational Site Number 392121
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Matsumoto-Shi : Investigational Site Number 392112
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Matumoto : Investigational Site Number 392108
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Midori-Shi : Investigational Site Number 392103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Mito-Shi : Investigational Site Number 392107
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Nagoya-Shi : Investigational Site Number 392112
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Nishinomiya-Shi : Investigational Site Number 392120
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Osaka-Shi : Investigational Site Number 392113
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Osaka-Shi : Investigational Site Number 392116
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Osaka-Shi : Investigational Site Number 392118
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Sakai-Shi : Investigational Site Number 392101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Shinjuku-Ku : Investigational Site Number 392104
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Shinjuku-Ku : Investigational Site Number 392105
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Shizuoka-Shi : Investigational Site Number 392111
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Takatsuki-Shi : Investigational Site Number 392114
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Tokushima-Shi : Investigational Site Number 392122
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Tomioka-Shi : Investigational Site Number 392103
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Tomishiro : Investigational Site Number 392102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Ushiku-Shi : Investigational Site Number 392102
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Yamagata-Shi : Investigational Site Number 392106
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Yokohama-Shi : Investigational Site Number 392108
Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus
Latvia
Limbazi : Investigational Site Number 428106
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Riga : Investigational Site Number 428103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Riga : Investigational Site Number 428105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Sigulda : Investigational Site Number 428102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Ventspils : Investigational Site Number 428101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Lithuania
Jonava : Private Clinic JSC 'Kristavita'
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Kaunas : Kaunas Medical University Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Vilnius : Vilnius Medical University Hospital, Santariskiu Clinic's
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Vilnius : Public Institution 'Seskines Outpatient Clinic'
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Netherlands
Almere : Investigational Site Number 528101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Beek : Investigational Site Number 528103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Nijmegen : Investigational Site Number 528105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Venlo : Investigational Site Number 528104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Zwijndrecht : Investigational Site Number 528102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Philippines
Makati City : Beverly Hills Medical Group
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes
Quezon City : Veterens Memorial Medical Centre
Safety and Efficacy of Autologous Adipose-Derived Stem Cell Transplantation in Patients With Type 1 Diabetes
Poland
Lodz : NZOZ OmniMed
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Puerto Rico
Ponce : Investigational Site Number 840602
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Ponce : Investigational Site Number 840601
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Romania
Bacau : Investigational Site Number 642107
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Brasov : Investigational Site Number 642103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Oradea : Investigational Site Number 642109
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Resita : Investigational Site Number 642106
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Sibiu : Investigational Site Number 642104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
View More »
Targu Mures : Investigational Site Number 642101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Targu Mures : Investigational Site Number 642102
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Timisoara : Investigational Site Number 642108
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Timisoara : Investigational Site Number 642105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Russian Federation
Chelyabinsk : State Educational Institution for Additional Professional Education (SEIAPE) "Ural State Medical
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Kemerovo : Kemerovo Regional Clinical Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Moscow : City Clinical Hospital #81, Endocrinology Department
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Moscow : Endocrinological scientific center of Rosmedtechnology
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Moscow : Clinic of New Medical Technology, LLC
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
View More »
Moscow : SEIAPE Endocrinology and Diabetology
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Nizhni Novgorod : State Healthcare Institution (SHI) "Nizhegorodskaya
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Perm : State Healthcare Institution Perm Region Clinical Hospital
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Samara : Limited Liability Company (LLC), Diabetes Center
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
St Petersburg : State Educational Institution of Higher Professional Education
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
St. Petersburg : St. Petersburg State Healthcare Institution
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Tomsk : Siberian State Medical University of Roszdrav
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Spain
Las Palmas de Gran Canaria : Complejo Hospitalario Universitario Insular Materno-Infantil
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Lleida : Hospital Universitari Arnau de Vilanova
Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults
Oviedo : Hospital Universitario Central de Asturias
Stem Cell Educator Therapy in Type 1 Diabetes
Sweden
Goteborg : Investigational Site Number 752103
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Kristianstad : Investigational Site Number 752105
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Stockholm : Investigational Site Number 752101
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Vällingby : Investigational Site Number 752104
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus
Switzerland
Basel : University Hospital Basel
Effects of XOMA 052 on Insulin Production in Type 1 Diabetes
United Kingdom
Cambridge : Cambridge University Hospitals NHS Foundation Trust
Short Term Closed-loop Glucose Control in Adults With Type 1 Diabetes
Glasgow :
REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
High Wycombe : Wycombe Hospital
Comparing Long-acting Insulins During Exercise in Type 1 Diabetes
Swansea : Clinical Research Unit
Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA)
